Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer's Disease: A Systematic Review and Meta-Analysis-Reference-Cited by-同舟云学术

Efficacy and Safety of Donepezil, Galantamine, Rivastigmine, and Memantine for the Treatment of Alzheimer's Disease: A Systematic Review and Meta-Analysis

Published:2014-06-23 Issue:2 Volume:41 Page:615-631
ISSN:1875-8908
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Tan Chen-Chen¹,Yu Jin-Tai¹²³,Wang Hui-Fu²,Tan Meng-Shan³,Meng Xiang-Fei¹,Wang Chong¹,Jiang Teng²,Zhu Xi-Chen²,Tan Lan¹²³

Affiliation:

1. Department of Neurology, Qingdao Municipal Hospital, School of Medicine, Qingdao University, Qingdao, China

2. Department of Neurology, Qingdao Municipal Hospital, Nanjing Medical University, Nanjing, China

3. Department of Neurology, Qingdao Municipal Hospital, College of Medicine and Pharmaceutics, Ocean University of China, Qingdao, China

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Cited by 384 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In Silico Prediction of Quercetin Analogs for Targeting Death-Associated Protein Kinase 1 (DAPK1) Against Alzheimer’s Disease;Current Neuropharmacology;2024-12

2. Exploring the anti-Alzheimer potential: Design, synthesis, biological activity, and molecular docking study of benzothiazol-1,3,4-oxadiazole-acetamide compounds;Journal of Molecular Structure;2024-12

3. Multifunctional anti-Alzheimer's agents: Synthesis, biological evaluation, and molecular docking study of new 2-phenoxyacetamide/3-phenoxypropanamide/4-oxobutanamide derivatives;Journal of Molecular Structure;2024-12

4. A multifunctional natural treasure based on a “one stone, many birds” strategy for designing health-promoting applications: Tordylium apulum;Food Bioscience;2024-12

5. Design, synthesis and anti-Alzheimer's disease activity evaluation of C-3 arylated huperzine A derivatives;Fitoterapia;2024-09